Nu Skin Enterprises 株価情報 (NYSE: NUS)

Nu Skin Enterprises (NYSE:NUS) 株価情報

Nu Skin Enterprises

Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

Nu Skin Enterprises Inc

Nuveen ESG 1-5 Year U.S. Aggregate Bond ETF

Nuveen Ultra Short Income ETF

Nuveen ESG Small-Cap ETF

NEOS ETF Trust Nasdaq-100 Hedged Equity Income ETF (New)

NAUTILUS MINERALS INC ORD by Nautilus Minerals Inc.

NEW SOURCE ENGY PFD UTS by New Source Energy Partners LP

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite surging past the 20,000 level on Friday.
The Dow traded down 0.22% to 44,613.02 while the NASDAQ rose 0.31% to 20,008.02. The S&amp;P 500 also rose, gaining, 0.08% to 6,119.78.
Check This Out: <a href="https://in.benzinga.com/25/02/43729408/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Energy shares jumped by 0.5% on Friday.
In trading on Friday, health care shares fell by 0.8%.
Top Headline
The total number of active U.S. oil rigs increased by one to 481 rigs this week, Baker Hughes Inc reported.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>WeRide Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) shares shot up 82% to $31.19 after Nvidia disclosed a stake of 1.74 million shares in a 13F filing.</li>
<li>Shares of Jet.AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>)got a boost, surging 122% to $5.74 after the company announced it will be acquired by flyExclusive.</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) shares were also up, gaining 19% to $7.62 following upbeat quarterly earnings.</li>
</ul>
Equities Trading DOWN
<ul>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) shares dropped 29% to $10.77 after Nvidia disclosed in a 13F filing that it dissolved its stake in the company.</li>
<li>Shares of Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) were down 43% to $13.18 after an amended 13G filing shows NVIDIA holds no stake in the company.</li>
<li>Informatica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFA#NASDAQ">INFA</a>) was down, falling 26% to $18.65 after the company reported worse-than-expected fourth-quarter sales results and issued FY25 revenue guidance below estimates. Multiple analysts downgraded the stock following the report.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $70.92 while gold traded down 1.6% at $2,897.80.
Silver traded up 0.3% to $32.820 on Friday, while copper fell 2.5% to $4.6605.
Euro zone
European shares closed mixed today. The eurozone's STOXX 600 fell 0.24%, Germany's DAX 40 fell 0.44% and France's CAC 40 rose 0.18%. Spain's IBEX 35 Index rose 0.15%, while London's FTSE 100 fell 0.37%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 falling 0.79%, China's Shanghai Composite Index gaining 0.43%, Hong Kong's Hang Seng Index gaining 3.69% and India's BSE Sensex falling 0.26%.
Economics
<ul>
<li>U.S. retail sales fell 0.9% month-over-month in January, compared to market estimates of a 0.1% decline, and versus a revised 0.7% increase in December.</li>
<li>U.S. export prices increased by 1.3% in January, while import prices in the U.S. climbed by 0.3% from the previous month during January.</li>
<li>U.S. industrial production rose by 0.5% in January versus a revised 1% gain in December.</li>
<li>The total number of active U.S. oil rigs increased by one to 481 rigs this week, Baker Hughes Inc reported.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://in.benzinga.com/trading-ideas/short-ideas/25/02/43730195/top-3-defensive-stocks-that-may-collapse-in-q1">Top 3 Defensive Stocks That May Collapse In Q1</a></li>
</ul>

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

INFA

JTAI

SERV

SOUN

Nasdaq Surges Above 20,000; Crude Oil Moves Lower

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&amp;P 500 and Nasdaq trading just above the flatline Friday. Traders are digesting weaker-than-expected retail sales and the potential for peace talks<a href="https://www.benzinga.com/news/global/25/02/43732115/explosion-rocks-chernobyl-nuclear-site-as-zelenskyy-signals-readiness-for-peace-talks"> between Russia and Ukraine.&nbsp;</a>
Retail sales in the U.S. fell 0.9% month-over-month in January, significantly worse than the anticipated 0.1% drop. However, markets are largely shrugging off the weaker-than-expected retail sales figures which were likely affected by January's cold weather and California wildfires, as well as the upward revision of December results.
Geopolitical tensions eased slightly after Ukrainian President Volodymyr Zelenskyy<a href="https://www.benzinga.com/news/global/25/02/43732115/explosion-rocks-chernobyl-nuclear-site-as-zelenskyy-signals-readiness-for-peace-talks"> told reporters</a> at the Munich Security Conference on Friday that he is willing to participate in Trump&#8217;s peace initiative and eventual talks with Russia.
The price of Crude Oil slid another 0.52% Friday and is down 9.9% over the past month as the market reacted to President Donald Trump&#8216;s plans to impose reciprocal tariffs on trade partners and news of potential peace talks to end the war in Ukraine.
The yield on the 10-year U.S. Treasury note fell to below the 4.5% threshold on Friday, extending its pullback after January's retail sales data may have indicated some weakness in the U.S. consumer. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) rose 0.7%. 
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rose above the $98,000 level on a midday rally Friday and XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) climbed more than 7%. 
<h2 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h2>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Major Indices </td>
<td>Price</td>
<td>1 day % chg.</td>
</tr>
<tr>
<td>Nasdaq 100 </td>
<td>19,988.34</td>
<td>0.20%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,116.90</td>
<td>0.03%</td>
</tr>
<tr>
<td>Dow Jones </td>
<td>44,602.67</td>
<td>-0.24%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,278.93</td>
<td>-0.14%</td>
</tr>
</tbody>
</table>
</figure>
According to Benzinga Pro data:
<ul>
<li>The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched up 0.3% to $609.92</li>
<li>The SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) was down 0.23% at $446.24</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.27% to $537.34.&nbsp;</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.14% to $225.82.</li>
<li>The Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) dipped 0.14% to $226.78</li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) rose 0.72% to $90.36.&nbsp;</li>
</ul>
<h2 class="wp-block-heading">Friday's Stock Movers:&nbsp;</h2>
Shares of Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) and SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) tanked after NVIDIA Corp.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) latest 13F filing revealed it had dissolved its stakes in both companies.&nbsp;
Stocks reacting to company earnings reports included:&nbsp;
<ul>
<li>DraftKings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>)&nbsp;</li>
<li>American Axle &amp; Manufacturing Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>)&nbsp;</li>
<li>Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>)&nbsp;</li>
<li>JFrog, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>)&nbsp;</li>
<li>Wynn Resorts Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>)&nbsp;</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>)&nbsp;</li>
<li>Palo Alto Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>)</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>)&nbsp;</li>
<li>Procore Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>)&nbsp;</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)&nbsp;</li>
<li>Udemy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UDMY#NASDAQ">UDMY</a>)&nbsp;</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>)&nbsp;</li>
<li>Bio-Rad Laboratories, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIO#NYSE">BIO</a>)&nbsp;</li>
</ul>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/02/43703014/robert-f-kennedy-confirmed-as-trump-secretary-of-health">Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump&#8217;s Secretary Of Health: Health Care Stocks To Watch</a></li>
</ul>
Image: Shutterstock

$BTC

$XRP

COIN

SPDR Dow Jones Industrial Average ETF Trust

DKNG

DXCM

FROG

MRNA

NVDA

PANW

PCOR

ROKU

iShares Trust Barclays 20+ Year Treasury Bond Fund

UDMY

WYNN

Select Sector SPDR-Consumer Discretionary

Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?

WIIM

Nu Skin Enterprises shares are trading higher following a Q4 earnings beat.

U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 100 points on Friday.
The Dow traded down 0.24% to 44,605.35 while the NASDAQ rose 0.03% to 19,951.12. The S&amp;P 500 also fell, dropping, 0.06% to 6,111.64.
Check This Out: <a href="https://in.benzinga.com/25/02/43729408/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Energy shares jumped by 0.7% on Friday.
In trading on Friday, consumer staples shares fell by 0.9%.
Top Headline
U.S. industrial production rose by 0.5% in January versus a revised 1% gain in December.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>WeRide Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) shares shot up 82% to $31.33 after Nvidia disclosed a stake of 1.74 million shares in a 13F filing.</li>
<li>Shares of Jet.AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>)got a boost, surging 125% to $5.80 after the company announced it will be acquired by flyExclusive.</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) shares were also up, gaining 22% to $7.83 following upbeat quarterly earnings.</li>
</ul>
Equities Trading DOWN
<ul>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) shares dropped 30% to $10.76 after Nvidia disclosed in a 13F filing that it dissolved its stake in the company.</li>
<li>Shares of Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) were down 43% to $13.16 after an amended 13G filing shows NVIDIA holds no stake in the company.</li>
<li>Informatica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFA#NASDAQ">INFA</a>) was down, falling 30% to $17.56 after the company reported worse-than-expected fourth-quarter sales results and issued FY25 revenue guidance below estimates. Multiple analysts downgraded the stock following the report.</li>
</ul>
Commodities In commodity news, oil traded down 0.6% to $70.90 while gold traded down 1.2% at $2,910.00.
Silver traded up 0.4% to $32.850 on Friday, while copper fell 2.5% to $4.6575.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 fell 0.24%, Germany's DAX 40 fell 0.44% and France's CAC 40 rose 0.18%. Spain's IBEX 35 Index rose 0.15%, while London's FTSE 100 fell 0.37%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 falling 0.79%, China's Shanghai Composite Index gaining 0.43%, Hong Kong's Hang Seng Index gaining 3.69% and India's BSE Sensex falling 0.26%.
Economics
<ul>
<li>U.S. retail sales fell 0.9% month-over-month in January, compared to market estimates of a 0.1% decline, and versus a revised 0.7% increase in December.</li>
<li>U.S. export prices increased by 1.3% in January, while import prices in the U.S. climbed by 0.3% from the previous month during January.</li>
<li>U.S. industrial production rose by 0.5% in January versus a revised 1% gain in December.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://in.benzinga.com/trading-ideas/short-ideas/25/02/43730195/top-3-defensive-stocks-that-may-collapse-in-q1">Top 3 Defensive Stocks That May Collapse In Q1</a></li>
</ul>

Earnings

Dow Falls 100 Points; US Industrial Output Increases In January

U.S. stocks were mostly lower, with the Dow Jones falling around 100 points on Friday.
Shares of The Goodyear Tire &amp; Rubber Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/GT/analyst-ratings">quarterly financial results</a>.
Goodyear Tire &amp; Rubber reported quarterly earnings of 39 cents per share which beat the analyst consensus estimate of 31 cents per share. The company reported quarterly sales of $4.95 billion which beat the analyst consensus estimate of $4.87 billion.
Goodyear Tire &amp; Rubber shares jumped 19.4% to $9.76 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>WeRide Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) shares jumped 97.7% to $33.94 after Nvidia disclosed a stake of 1.74 million shares in a 13F filing.</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) gained 34.6% to $8.65 following upbeat quarterly earnings.</li>
<li>Udemy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UDMY#NASDAQ">UDMY</a>) gained 23.7% to $9.67 after the company reported fourth-quarter earnings and revenue above estimates.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) rose 20.9% to $1.7900 following upbeat quarterly earnings.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) gained 20.3% to $20.86.</li>
<li>Personalis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>) gained 17.2% to $5.85.</li>
<li>TreeHouse Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) gained 17% to $38.90 following fourth-quarter results.</li>
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) climbed 16% to $17.25.</li>
<li>Airbnb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) gained 15.8% to $163.43 following a quarterly revenue beat. Multiple analysts upgraded the stock following the report.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) rose 15.2% to $100.00 following better-than-expected quarterly financial results.</li>
<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) gained 14.8% to $32.85.</li>
<li>CAE Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>) rose 14.7% to $26.98 after the company reported a year-over-year increase in third-quarter financial results.</li>
<li>DraftKings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) gained 13.3% to $52.62 after the company reported better-than-expected quarterly adjusted EPS results and raised its FY25 revenue guidance.</li>
<li>West Pharmaceutical Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) rose 11.2% to $221.56.</li>
<li>Pilgrim&#8217;s Pride Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPC#NASDAQ">PPC</a>) gained 9.6% to $57.07.</li>
<li>Tencent Music Entertainment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) rose 5.3% to $13.43</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43692962/top-3-consumer-stocks-you-may-want-to-dump-in-february">Top 3 Consumer Stocks You May Want To Dump In February</a></li>
</ul>

Movers

ABNB

BEAM

PACB

PONY

PSNL

Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday

Shares of Airbnb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) rose sharply in today's pre-market trading after the company reported its <a href="https://in.benzinga.com/general/market-summary/25/02/43722350/airbnb-crushes-q4-estimates-as-classic-hotel-users-flock-to-short-term-rentals-heres-whats-driving-the-surge-in-nights-and-experiences">fourth-quarter financial results.</a>
Airbnb reported quarterly revenue of $2.5 billion which beat the $2.42 billion analyst consensus estimate and represents an increase of 12% year-over-year.&nbsp; The company said the increase in revenue was driven by strong growth in nights stayed and a modest increase in ADR.
Airbnb shares jumped 13.9% to $160.58 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) gained 78.4% to $0.5157 in pre-market trading after the company announced it confirmed positive results from its Probudur for combat care study with the U.S. Army.</li>
<li>Moleculin Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) rose 62.2% to $2.06 in pre-market trading after jumping 202% on Thursday. The company received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 pivotal trial protocol evaluating Annamycin in combination with Cytarabine (also known as Ara-C and for which the combination of Annamycin and Ara-C is referred to as AnnAraC) for refractory/relapsed Acute Myeloid Leukemia patients.</li>
<li>Zoomcar Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares jumped 36.4% to $2.02 in pre-market trading ahead of quarterly earnings.</li>
<li>ScanTech AI Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAI#NASDAQ">STAI</a>) gained 39.3% to $2.34 in pre-market trading after gaining 17% on Thursday.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) gained 27.2% to $2.25 in pre-market following a 21% gain in the previous session.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) shares climbed 22.4% to $0.1320 in pre-market trading after gaining around 4% on Thursday.</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) gained 20.4% to $7.73 in pre-market trading after posting upbeat quarterly earnings.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) gained 17.9% to $20.46 in pre-market trading after falling around 4% on Thursday.</li>
<li>Zhihu Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) gained 15.2% to $5.30 in pre-market trading after jumping over 10% on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>PicoCELA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCLA#NASDAQ">PCLA</a>) shares fell 54.6% to $3.65 in pre-market trading after declining around 5% on Thursday.</li>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares fell 39% to $0.2585 in pre-market trading. Mynaric shares dipped around 32% on Thursday after company announced it received a delisting notification from the Nasdaq.</li>
<li>Unifi, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UFI#NYSE">UFI</a>) dipped 34.5% to $3.70 in pre-market trading after gaining 11% on Thursday.</li>
<li>Bellevue Life Sciences Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLAC#NASDAQ">BLAC</a>) fell 36.3% to $4.29 in today's pre-market trading. The company announced approval for a business combination proposal and name change with OSR Holdings beginning on February 18.</li>
<li>Jerash Holdings (US), Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRSH#NASDAQ">JRSH</a>) fell 37% to $2.40 in pre-market trading.</li>
<li>Informatica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFA#NYSE">INFA</a>) shares tumbled 35.6% to $16.21 in pre-market trading after the company reported worse-than-expected fourth-quarter sales results and issued FY25 revenue guidance below estimates.</li>
<li>Bolt Projects Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>) declined 31.8% to $0.8393 in pre-market trading. Bolt Projets Holdings shares jumped 303% on Thursday after the company, on X, posted, &#8220;Another exciting partnership coming soon, powered by Bolt.&#8221;</li>
<li>Solaris Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#NYSE">SLSR</a>) fell 22.5% to $3.20 in pre-market trading after gaining 3% on Thursday.</li>
<li>Stevanato Group S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STVN#NYSE">STVN</a>) fell 16.1% to $16.01 in pre-market trading after declining 5% on Thursday.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) shares dipped 13.2% to $25.25 in pre-market trading following downbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43692962/top-3-consumer-stocks-you-may-want-to-dump-in-february">Top 3 Consumer Stocks You May Want To Dump In February</a></li>
</ul>

BLAC

BSLK

CNSP

FFIE

JRSH

MBRX

MYNA

PCLA

SLSR

STAI

STVN

VRPX

ZCAR

Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Guidance

Nu Skin Sees Q1 Adj. EPS $0.10-$0.20 vs. $0.15 Est., Revenue $345M-$365M vs. $399.796M Est.; Nu Skin Sees FY25 Adj. EPS $0.90-$1.30 vs. $0.84 Est., Revenue $1.48B-$1.62B vs. $1.695B Est.

Earnings Beats

Nu Skin Enterprises Q4 2024 Adj. EPS $0.38 Beats $0.22 Estimate, Sales $445.600M Beat $435.989M Estimate

AENT

AGIO

ALNY

AMAT

APDN

ATUS

AVNT

BENF

BFAM

BLIN

BPMC

BRKR

BTOC

CBRE

CEVA

CLBT

CNVS

COHU

CROX

CYBR

DDOG

DNOW

EEFT

EGAN

ELME

ELVA

FBRT

GDDY

GEHC

GPMT

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HIMX

HOUS

HTGC

IMPP

IRDM

IRMD

ISSC

KELYA

KELYB

KNSL

LECO

LGCY

LPTH

NTWK

NVMI

Earnings Scheduled For February 13, 2025

Nu Skin shares are trading higher after the company announced expectations for preliminary Q4 revenue to be at the high end of the guidance range.

U.S. stocks were mixed, with the Dow Jones index gaining over 200 points on Monday.
Shares of Intra-Cellular Therapies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>) rose sharply during Monday's session after Johnson &amp; Johnson agreed to acquire the company for $132.00 per share in cash for a total equity value of <a href="https://www.benzinga.com/general/biotech/25/01/42948170/like-bristol-myers-squibb-and-abbvie-johnson-johnson-seeks-to-bolster-neuropsychiatric-portfolio-with-15-billion-deal">approximately $14.6 billion</a>.
With this agreement, Johnson &amp; Johnson adds Intra-Cellular Therapies' Caplyta (lumateperone), a once-daily oral therapy approved to treat adults with schizophrenia, as well as depressive episodes associated with bipolar I or II disorder (bipolar depression), as a monotherapy and adjunctive therapy with lithium or valproate.
Intra-Cellular Therapies shares jumped 34.6% to $127.62 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Sage Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) shares jumped 35.5% to $7.52. On Friday, Sage Therapeutics confirmed that Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) submitted an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics not already owned by Biogen for $7.22 per share.</li>
<li>Standard BioTools Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAB#NYSE">LAB</a>) gained 24% to $2.0250 after the company announced preliminary fourth-quarter and FY24 financial results.</li>
<li>LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) rose 21% to $9.00 after Piper Sandler upgraded the stock from Underweight to Overweight and raised its price target from $9 to $11.</li>
<li>agilon health, inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) gained 17% to $2.86.</li>
<li>SI-BONE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) rose 14.1% to $15.66 after the company announced preliminary revenue for the fourth quarter and full year 2024.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) climbed 13.9% to $8.85.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) rose 13% to $39.92.</li>
<li>Radiopharm Theranostics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) climbed 12.2% to $6.00.</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) gained 11.4% to $6.93 as the company announced fourth-quarter preliminary revenue at high end of guidance.</li>
<li>Blueprint Medicines Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) rose 10.4% to $96.43 after the company reported a year-over-year increase in FY24 AYVAKIT revenue results.</li>
<li>Radiopharm Theranostics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) gained 10.3% to $5.90. Radiopharm Theranostics announced it will execute a private placement and will raise $5 million in proceeds.</li>
<li>United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) gained 8.5% to $37.15 amid a report that Cleveland-Cliffs will partner with Nucor to make a potential bid for the company.</li>
<li>Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) gained 6.6% to $286.90.</li>
<li>CF Industries Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) rose 6.3% to $94.35. Piper Sandler analyst Charles Neivert upgraded CF Industries Holdings from Underweight to Overweight and raised the price target from $79 to $105.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42947348/tesla-to-rally-around-9-here-are-10-top-analyst-forecasts-for-monday">Tesla To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Monday</a></li>
</ul>

BIIB

CRML

ITCI

RADX

SAGE

SIBN

Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday

Nu Skin Enterprises Expects Q4 Preliminary Revenue At High End Of Company's Guidance Range

U.S. stocks were higher, with the Dow Jones index gaining over 100 points on Friday.
Shares of Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) rose sharply during Friday's session. The company disclosed its production and delivery figures for the fourth quarter and <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42786671/why-is-rivian-automotive-stock-surging-today">full-year 2024</a>.
The company reported a 1.5% year-on-year rise in its fourth-quarter deliveries to 14,183 vehicles. The company produced 12,727 vehicles at its Normal, Illinois facility. The delivery numbers are in contrast to 10,018 electric vehicles in the third quarter, which was the lowest number of quarterly deliveries since the first quarter of 2023.
Rivian Automotive shares jumped 17.9% to $15.63 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Cerence Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNC#NASDAQ">CRNC</a>) shares jumped 56.1% to $12.39 after the company announced an expanded collaboration with NVIDIA to advance its CaLLM family of language models.</li>
<li>Quantum-Si incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) gained 27.7% to $5.44.</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) shares jumped 21.8% to $7.99 after the company announced its subsidiary sold the Mavely affiliate marketing platform for $250 million in a mixed cash and equity deal.</li>
<li>Neumora Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) shares surged 21.1% to $2.3850. HC Wainwright &amp; Co. analyst Douglas Tsao reiterated Neumora Therapeutics with a Buy and maintained a $30 price target.</li>
<li>Acelyrin, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRN#NASDAQ">SLRN</a>) gained 18.8% to $3.92 after the company announced it will reveal new Phase 2 results and Phase 3 plans for Subcutaneous Lonigutamab during a hosted virtual investor event.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) jumped 18.1% to $17.44.</li>
<li>Amprius Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NASDAQ">AMPX</a>) gained 17.8% to $3.3688.</li>
<li>KULR Technology Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) rose 16.4% to $3.5150.</li>
<li>Joby Aviation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) surged 15.3% to $9.33.</li>
<li>Archer Aviation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) gained 14.2% to $10.94.</li>
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) gained 11.8% to $24.43.</li>
<li>Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) rose 8.4% to $27.06.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) surged 8.1% to $19.14.</li>
<li>Riot Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) gained 8.1% to $11.31.</li>
<li>Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) rose 5.7% to $3.2050.</li>
<li>Vistra Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VST#NASDAQ">VST</a>) gained 5% to $156.96 after UBS raised its price target on the stock from $161 to $174.</li>
<li>Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) rose 4.6% to $90.76 after Raymond James upgraded the stock from Market Perform to Outperform and announced a price target of $115.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/25/01/42785203/tesla-to-351-here-are-10-top-analyst-forecasts-for-friday">Tesla To $351? Here Are 10 Top Analyst Forecasts For Friday</a></li>
</ul>

ACHR

AMPX

CRNC

JOBY

KULR

LCID

NMRA

OKLO

RIOT

RIVN

RKLB

SLRN

Rivian Automotive, Cerence, Nu Skin Enterprises And Other Big Stocks Moving Higher On Friday

Nu Skin Enterprises shares are trading higher after the company announced its subsidiary sold the Mavely affiliate marketing platform for $250 million in a mixed cash and equity deal.

Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) saw its shares rise on Friday following the announcement of a strategic transaction <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">by its Rhyz Inc. subsidiary.</a>
Rhyz has sold its Mavely affiliate marketing technology platform to Later, a portfolio company of Summit Partners, for approximately $250 million in cash and a minority equity stake in the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42781900/nu-skin-enterprises-announces-strategic-transaction-of-mavely-for-250-million" rel="noreferrer noopener">combined Later/Mavely business.</a>
The deal, which also includes $33 million to be paid to other equity holders in the Mavely business, is part of Nu Skin&#8217;s broader strategy to enhance its affiliate marketing efforts. Despite the sale, Mavely will continue to provide technology and social commerce capabilities to support Nu Skin&#8217;s affiliate marketing business.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42782379/asia-markets-mixed-while-europe-dips-gold-flat-and-oil-prices-ease-slightly-global-markets-today-while-us-slept" rel="noreferrer noopener">Dollar Hits New 2-Year High; Asia Markets Mixed, Europe Dips &#8211; Global Markets Today While Us Slept</a>
Ryan Napierski, Nu Skin&#8217;s president and CEO, expressed confidence in the transaction, highlighting how the combination of Later and Mavely will help accelerate the company&#8217;s vision for its beauty, wellness, and lifestyle ecosystem. Napierski also noted that the deal strengthens Nu Skin&#8217;s balance sheet, generating additional capital to increase innovation in its core business and investments in Rhyz companies.
This strategic move has resulted in an approximate five-times return on Nu Skin&#8217;s cumulative investment in Mavely since its acquisition in 2021. The proceeds from the transaction are expected to be used for debt reduction, further innovation, and stock buybacks under Nu Skin&#8217;s repurchase program, aiming to provide value to its shareholders.
Price Action: NUS shares are trading higher by 16.5% to $7.64 premarket at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42779827/joe-biden-to-decide-on-nippon-steels-14-9b-us-steel-acquisition-on-friday-amid-veto-offer-labor-concerns" target="_blank" rel="noreferrer noopener">Joe Biden To Decide On Nippon Steel&#8217;s $14.9B US Steel Acquisition On Friday Amid Veto Offer, Labor Concerns</a></li>
</ul>
Photo via Shutterstock.

Asset Sales

General

Why Is Nu Skin Enterprises Stock Jumping Today?

Approximately $33 million of such consideration will be paid to other equity holders in the Mavely business. In connection with the transaction, Mavely is expected to continue to provide certain technology and social commerce capabilities to support Nu Skin's affiliate marketing business.
"Together, we believe Later and Mavely will provide enhanced capabilities to our company as we pursue our broader beauty, wellness and lifestyle ecosystem vision, while the transaction generates additional capital and resources for us to increase innovation in our core Nu Skin business and investment in our Rhyz companies," said Ryan Napierski, Nu Skin president and CEO. "This underscores the value of Rhyz to incubate and scale meaningful businesses with synergistic value across the enterprise."
This transaction generated an approximate five-times return on the company's cumulative investment in Mavely since it was acquired in 2021. Proceeds from the transaction are expected to be used to pay down debt and fund additional innovation. The company also plans to use its strengthened balance sheet to buy back stock under its existing stock repurchase program, providing value to its shareholders.
Evercore Group LLC acted as exclusive financial advisor and Simpson Thacher &amp; Bartlett LLP acted as legal counsel to Nu Skin Enterprises.

Nu Skin Enterprises' Rhyz Subsidiary Sells Mavely Affiliate Marketing Platform To Later For $250M In Cash and Equity, Retains Minority Stake In Combined Later/Mavely Business

DA Davidson analyst Linda Bolton Weiser maintains Nu Skin Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) with a Neutral and lowers the price target from $11 to $7.

Price Target

Analyst Ratings

DA Davidson Maintains Neutral on Nu Skin Enterprises, Lowers Price Target to $7

Nu Skin Sees Q4 Adj. EPS $0.19-$0.29 vs $0.28 Est., Revenue $410M-$445M vs $455.83M Est.; Sees 2024 Adj. EPS $0.65-$0.75 vs $0.77 Est., Revenue $1.7B-$1.73B vs $1.75B Est.

Nu Skin Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.14 by 21.43 percent. The company reported quarterly sales of $430.100 million which missed the analyst consensus estimate of $440.954 million by 2.46 percent. This is a 13.77 percent decrease over sales of $498.772 million the same period last year.

Earnings Misses

Nu Skin Enterprises Q3 2024 GAAP EPS $0.17 Beats $0.14 Estimate, Sales $430.100M Miss $440.954M Estimate

Social Media

Press Releases

Mavely Streamlines Creator Experience from Post to Purchase with New LinkDM and Button Partnerships and MyShop Upgrades

Nu Skin Introduces MYND360™, a New Line of Clinically Proven Supplements and Topicals for Mental Well-Being

Later Drives Full-Funnel Influencer Marketing Impact with New Affiliate Campaign Capabilities, Leveraging a Strategic Partnership with Mavely

Nu Skin Enterprises Announces Quarterly Dividend

Nu Skin Enterprises Reports Third Quarter Results

Nu Skin Enterprises Announces Strategic Transaction of Mavely for $250 Million

Later Acquires Mavely for $250 Million, Unlocking New Opportunities for Marketers and Creators to Maximize their Return on Social

Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance

Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance

Comments

Nu Skin Enterprises

ニュース

パートナーシップ

ベンジンガ・グローバル